Kymera Therapeutics
KYMR
KYMR
129 hedge funds and large institutions have $1.34B invested in Kymera Therapeutics in 2023 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 49 increasing their positions, 32 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 126 → 129 (+3)
20% less capital invested
Capital invested by funds: $1.68B → $1.34B (-$340M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
129
Holding in Top 10
4
Calls
$1.86M
Puts
$443K
Top Buyers
| 1 | +$34.4M | |
| 2 | +$12.2M | |
| 3 | +$7.83M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$6.42M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$6.07M |
Top Sellers
| 1 | -$23.6M | |
| 2 | -$19.3M | |
| 3 | -$12.5M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$8.22M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$3.66M |